Everyone’s strapped for cash – except pharma. But the latest spending spree is no more of a fix for expiring patents than botox is for ageing skin, writes Nuala Moran.
The future of early-stage bioscience firms in the UK is in doubt and funding for start-ups has virtually ceased, says a report commissioned by the UK government.
The Norwegian Government is weighing a Euro 300M rescue package for the biotech industry as part of a national financial rescue package it is due to announce by the end of January.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.